Experimental condensation inhibition in constitutive and facultative heterochromatin of mammalian chromosomes.
What drives the dramatic changes in chromosome structure during the cell cycle is one of the oldest questions in genetics. During mitosis, all chromosomes become highly condensed and, as the cell completes mitosis, most of the chromatin decondenses again. Only chromosome regions containing constitutive or facultative heterochromatin remain in a more condensed state throughout interphase. One approach to understanding chromosome condensation is to experimentally induce condensation defects. 5-Azacytidine (5-aza-C) and 5-azadeoxycytidine (5-aza-dC) drastically inhibit condensation in mammalian constitutive heterochromatin, in particular in human chromosomes 1, 9, 15, 16, and Y, as well as in facultative heterochromatin (inactive X chromosome), when incorporated into late-replicating DNA during the last hours of cell culture. The decondensing effects of 5-aza-C analogs, which do not interfere with normal base pairing in substituted duplex DNA, have been correlated with global DNA hypomethylation. In contrast, decondensation of constitutive heterochromatin by incorporation of 5-iododeoxyuridine (IdU) or other non-demethylating base analogs, or binding of AT-specific DNA ligands, such as berenil and Hoechst 33258, may reflect an altered steric configuration of substituted or minor-groove-bound duplex DNA. Consequently, these compounds exert relatively specific effects on certain subsets of AT-rich constitutive heterochromatin, i.e. IdU on human chromosome 9, berenil on human Y, and Hoechst 33258 on mouse chromosomes, which provide high local concentrations of IdU incorporation sites or DNA-ligand-binding sites. None of these non-demethylating compounds affect the inactive X chromosome condensation. Structural features of chromosomes are largely determined by chromosome-associated proteins. In this light, we propose that both DNA hypomethylation and steric alterations in chromosomal DNA may interfere with the binding of specific proteins or multi-protein complexes that are required for chromosome condensation. The association between chromosome condensation defects, genomic instability, and epigenetic reprogramming is discussed. Chromosome condensation may represent a key ancestral mechanism for modulating chromatin structure that has since been realloted to other nuclear processes.
Haaf
T
T
Max-Planck-Institut für Molekulare Genetik, Berlin , Germany. haaf@molgen.mpg.de
Schmid
M
M
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D002460:Cell Line; D002877:Chromosomes, Human / Q000737:chemistry* / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D019175:DNA Methylation / Q000187:drug effects; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D019143:Evolution, Molecular; D020868:Gene Silencing / Q000187:drug effects; D006570:Heterochromatin / Q000737:chemistry* / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007621:Karyotyping; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D008968:Molecular Conformation; D012730:Sex Chromosomes / Q000737:chemistry / Q000187:drug effects / Q000235:genetics / Q000378:metabolism
D000964:Antimetabolites, Antineoplastic; D006570:Heterochromatin; D000077209:Decitabine; D015254:DNA Modification Methylases; D001374:Azacitidine